Richards Group Reports Q3 Revenue Growth Driven by PharmaSystems Acquisition
Richards Group reported a 1.8% year-over-year increase in third-quarter revenue, largely attributed to the integration of PharmaSystems, which was acquired in May 2026. The company saw a significant improvement in gross margins, rising 6.5% year-over-year, as a shift toward higher-margin healthcare products bolstered the overall mix. While the healthcare segment experienced growth driven by consumables and low-price capital equipment, the packaging division faced headwinds. Packaging revenue fell 7.3% year-over-year, though this represents an improvement over the 14.4% decline observed during the first half of 2026.
Tickers: $RPKIF
Topics: acquisition impact gross margins revenue growth segment performance
Read the full article at Seeking Alpha
Part of the story Curbline Properties Reports Q3 2026 Growth Driven by Asset Acquisitions and Increased Investment Targets (12 articles)